This weekend at the ASH Meeting on Hematological Malignancies (ASHMHM15), Lymphoma Program Director, Dr. John Leonard will discuss how he treats patients with mantle cell lymphoma, and specifically on how to overcome mantle cell lymphoma resistance to ibrutinib.
Author: lymphomaprogram
Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.
View all posts by lymphomaprogram
New Developments in Lymphoma 